Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prostate Brachytherapy Sources Vary By $5,570, Violate 2X Rule – CAB Data

This article was originally published in The Gray Sheet

Executive Summary

Brachytherapy seeds for prostate cancer should be reimbursed by Medicare on a per-seed basis under the hospital outpatient prospective payment system, the Coalition for the Advancement of Brachytherapy (CAB) contends in Sept. 24 comments to CMS

You may also be interested in...



Brachytherapy Bill Could Be Included In Larger Medicare Package – Staffers

Theragenics is seeking a Senate sponsor for legislation that would oblige CMS to establish separate reimbursement for the number, isotope and radioactive intensity of sources used in brachytherapy under the hospital outpatient prospective payment system

Brachytherapy Bill Could Be Included In Larger Medicare Package – Staffers

Theragenics is seeking a Senate sponsor for legislation that would oblige CMS to establish separate reimbursement for the number, isotope and radioactive intensity of sources used in brachytherapy under the hospital outpatient prospective payment system

OPPS Rule Establishes Separate Palladium, Iodine G Codes For Brachytherapy

The Centers for Medicare & Medicaid Services will establish two new G codes to track prostate brachytherapy procedures, under the 2003 hospital outpatient prospective payment system final rule

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel